| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8746564 | Journal of Global Antimicrobial Resistance | 2017 | 5 Pages |
Abstract
FOF presented good activity even against carbapenem-resistant isolates and may be a treatment alternative for non-UTI isolates, but should be used with caution for infections related to ESBL-producing Klebsiella spp.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Tulin Demir, Tuncay Buyukguclu,